Alterity Therapeutics Limited
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Show More...
-
Website https://alteritytherapeutics.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.01 EUR
-
Last Updated 12-12-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 TTM Earnings Per Share AUD -0.02 -0.02 -0.02 -0.02 -0.03 -0.010 -0.010 -0.010 -0.02 -0.02 -0.02 Dividends AUD Payout Ratio % * Shares Mil 228.0 248.0 288.0 339.0 428.0 503.0 534.0 534.0 534.0 616.0 782.0 Book Value Per Share * EUR 0.02 0.010 0.02 0.03 0.05 0.05 0.03 0.02 0.010 0.010 Free Cash Flow Per Share * EUR -0.010 -0.02 -0.02 -0.010 -0.02 -0.010 -0.010 -0.010 Return on Assets % -86.1 -81.34 -64.08 -63.79 -45.4 -14.1 -20.46 -25.56 -37.57 -63.87 -88.28 Financial Leverage (Average) 1.3 1.3 1.31 1.22 1.1 1.07 1.08 1.07 1.16 1.2 1.29 Return on Equity % -109.3 -105.77 -83.47 -79.47 -51.6 -15.33 -21.93 -27.4 -41.57 -75.61 -114.26 Return on Invested Capital % -109.3 -105.71 -79.5 -75.07 -51.49 -15.33 -21.93 -27.4 -41.57 -75.61 -114.26 Interest Coverage -452.87 -439.55 -443.63 Current Ratio 4.47 4.3 4.24 5.48 10.51 15.35 14.28 15.88 7.06 5.98 4.43 Quick Ratio 3.48 4.26 4.2 5.44 10.5 15.3 14.16 15.7 6.96 5.79 4.34 Debt/Equity